MONTREAL, Oct. 15, 2024 (GLOBE NEWSWIRE) — Knight Therapeutics Inc., (TSX: GUD) (“Knight”) a pan-American (ex-USA) specialty pharmaceutical company, announced today that its Mexican affiliate, Grupo Biotoscana de Especialidad S.A. de C.V. has obtained regulatory approval by COFEPRIS, the Mexican health regulatory agency, for Minjuvi(R) (tafasitamab) in combination with lenalidomide followed by Minjuvi(R) monotherapy for […]

MISSISSAUGA, Ontario, Oct. 15, 2024 (GLOBE NEWSWIRE) — KP Tissue Inc. (“KPT”) (TSX:KPT), which holds an interest in Kruger Products Inc., will release the financial results for KPT and Kruger Products Inc. for the third quarter of 2024 on Wednesday, November 13, 2024 before the market opens. KPT will hold its conference call the same

MARKHAM, Ontario, Oct. 15, 2024 (GLOBE NEWSWIRE) — Sienna Senior Living Inc. (“Sienna” or the “Company“) (TSX: SIA) today announced a dividend of $0.078 per common share of the Company (each, a “Common Share“) for the month of October 2024, representing $0.936 per Common Share on an annualized basis. The dividend will be payable on

NEW YORK and TOKYO, Oct. 15, 2024 (GLOBE NEWSWIRE) — HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or “the Company”), a leading enterprise software and data consulting services company based in Tokyo, announced it has partnered with NTT Data Business Brains Corporation (“NTT Data Business Brains”) to implement the HeartCore CMS platform to expand NTT Data

SAN FRANCISCO, Oct. 15, 2024 (GLOBE NEWSWIRE) — Adaptive Research, a clinical trial site organization dedicated to democratizing clinical trials, announced its participation in a groundbreaking decentralized study for Parkinsons’ Disease sponsored by PhotoPharmics Inc. California Movement Disorders Center, part of Adaptive Research’s network, will serve as a site for PhotoPharmics’ LIGHT-PD trial, testing the

Amass Brands Group, a leading player in the global spirits industry, today announces the acquisition of Calirosa Tequila, a premium tequila brand known for its unique rosa tequila and distinctive flavor profiles. This strategic transaction marks a significant milestone for both companies, solidifying Amass Brands Group’s position in the premium spirits market and providing Calirosa

In the first year, Canine Parvovirus Monoclonal Antibodysaved thousands of puppies Elanco Animal Health today unleashed the first ever real-world data demonstrating the efficacy and impact of its Canine Parvovirus Monoclonal Antibody (CPMA), the first and only USDA Conditionally Approved targeted treatment for canine parvovirus. Annually, canine parvovirus affects more than 330,000 puppies, contributing up

KELOWNA, BC / ACCESSWIRE / October 15, 2024 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, today announced that it has entered into a definitive agreement for the purchase and sale of 1,633,987 shares of common stock at a purchase price of $3.06 per share in a

S&P Global (NYSE: SPGI)today announced the appointment of Eric Aboaf as Chief Financial Officer, effective February 2025. As an Executive Vice President and member of the Executive Leadership Team, Mr. Aboaf will oversee all aspects of the company’s Finance function. He will report to Ms. Martina L. Cheung, S&P Global’s incoming President and CEO. Ms.

Sphere Entertainment Co. (NYSE: SPHR) (“Sphere Entertainment”) and the Department of Culture and Tourism – Abu Dhabi (“DCT Abu Dhabi”) announced today that they will work together to bring the world’s second Sphere to Abu Dhabi, United Arab Emirates. This next-generation entertainment medium is expected to be a landmark addition to this premier international capital